Correlation Between Aerovate Therapeutics and Federal National

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Federal National at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Federal National into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Federal National Mortgage, you can compare the effects of market volatilities on Aerovate Therapeutics and Federal National and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Federal National. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Federal National.

Diversification Opportunities for Aerovate Therapeutics and Federal National

-0.52
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aerovate and Federal is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Federal National Mortgage in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Federal National Mortgage and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Federal National. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Federal National Mortgage has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Federal National go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Federal National

Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Federal National. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.14 times less risky than Federal National. The stock trades about -0.06 of its potential returns per unit of risk. The Federal National Mortgage is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  1,736  in Federal National Mortgage on December 3, 2024 and sell it today you would earn a total of  164.00  from holding Federal National Mortgage or generate 9.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Federal National Mortgage

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Federal National Mortgage 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Federal National Mortgage are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Federal National may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Aerovate Therapeutics and Federal National Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Federal National

The main advantage of trading using opposite Aerovate Therapeutics and Federal National positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Federal National can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Federal National will offset losses from the drop in Federal National's long position.
The idea behind Aerovate Therapeutics and Federal National Mortgage pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope